Publications
Pouliot J, Bani-Hashemi A, Chen J, Svatos M, Ghelmansarai F, Mitschke M, Aubin M, Xia P, Morin O, Bucci K, Roach M 3rd, Hernandez P, Zheng Z, Hristov D, Verhey L. Low-dose megavoltage cone-beam CT for radiation therapy. Int J Radiat Oncol Biol Phys 2005; 61(2):552-60.
Chen J, Chuang CF, Morin O, Aubin M, Pouliot J. Calibration of an amorphous-silicon flat panel portal imager for exit-beam dosimetry. Med Phys 2006; 33(3):584-94.
Hansen EK, Larson DA, Aubin M, Chen J, Descovich M, Gillis AM, Morin O, Xia P, Pouliot J. Image-guided radiotherapy using megavoltage cone-beam computed tomography for treatment of paraspinous tumors in the presence of orthopedic hardware. Int J Radiat Oncol Biol Phys 2006; 66(2):323-6.
Morin O, Gillis A, Chen J, Aubin M, Bucci MK, Roach M 3rd, Pouliot J. Megavoltage cone-beam CT: system description and clinical applications. Med Dosim 2006; 31(1):51-61.
Chen J, Morin O, Aubin M, Bucci MK, Chuang CF, Pouliot J. Dose-guided radiation therapy with megavoltage cone-beam CT. Br J Radiol 2006; 79(Spec No 1): S87-98.
Aubin M, Morin O, Chen J, Gillis A, Pickett B, Aubry JF, Akazawa C, Speight J, Roach M 3rd, Pouliot J. The use of megavoltage cone-beam CT to complement CT for target definition in pelvic radiotherapy in the presence of hip replacement. Br J Radiol 2006; 79(947): 918-21.
Morin O, Chen J, Aubin M, Gillis A, Aubry JF, Bose S, Chen H, Descovich M, Xia P, Pouliot J. Dose calculation using megavoltage cone-beam CT. Int J Radiat Oncol Biol Phys 2007; 67(4):1201-10.
Morin O, Gillis A, Descovich M, Chen J, Aubin M, Aubry JF, Chen H, Gottschalk AR, Xia P, Pouliot J. Patient dose considerations for routine megavoltage cone-beam CT imaging. Med Phys 2007; 34(5):1819-27.
Descovich M, Morin O, Aubry JF, Aubin M, Chen J, Bani-Hashemi A, Pouliot J. Characteristics of megavoltage cone-beam digital tomosynthesis. Med Phys 2008; 35(4):1310-6.
Sahgal A, Jabbari S, Chen J, Pickett B, Roach M 3rd, Weinberg V, Hsu IC, Pouliot J. Comparison of dosimetric and biologic effective dose parameters for prostate and urethra using 131Cs and 125I for prostate permanent implant brachytherapy. Int J Radiat Oncol Biol Phys 2008; 72(1):247-54.